1. Home
  2. Labeler Index
  3. Carilion Materials Management
  4. 68151-4679
  5. Product Images: Cymbalta

Product Images Cymbalta

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Cymbalta NDC 68151-4679 by Carilion Materials Management, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structural Formula - cymbalta 01

Structural Formula - cymbalta 01

Figure 3 - cymbalta 02

Figure 3 - cymbalta 02

Figure 4 - cymbalta 03

Figure 4 - cymbalta 03

Figure 5 - cymbalta 13

Figure 5 - cymbalta 13

Figure 6 - cymbalta 14

Figure 6 - cymbalta 14

Figure 7 - cymbalta 15

Figure 7 - cymbalta 15

This is a graph that shows the percentage of patients who have improved after taking either a placebo or CYM60/120 mg once daily. The X-axis shows the percentage improvement in pain from baseline, while the Y-axis shows the percentage of patients who have improved. The graph indicates that significantly more patients improve after taking CYM60/120 mg once daily than after taking a placebo.*

Figure 8 - cymbalta 16

Figure 8 - cymbalta 16

This is a graph depicting the percentage of patients improved in pain from baseline. It shows two different lines, one for placebo and the other for CYMB0 mg once daily. The graph ranges from 0% to 100% and shows the percentage of patients improved in increments of 10%.*

Figure 9 - cymbalta 17

Figure 9 - cymbalta 17

This text describes a chart showing the percentage of patients who have improved after taking a placebo or CYM60/120mg once daily. The chart also displays the percent improvement in pain from baseline (BOCF).*

Figure 1 - cymbalta 18

Figure 1 - cymbalta 18

This appears to be a graph showing the proportion of patients with relapse over time from randomization to relapse (in days). The graph includes two treatments, "Placebe" and "CYMBALTA". The x-axis shows time in days from 0 to 250, and the y-axis shows the proportion of patients with relapse, ranging from 0 to 1.0. The graph also includes tick marks at 50, 100, 150, and 200 on the x-axis.*

Figure 2 - cymbalta 19

Figure 2 - cymbalta 19

Label Image - lbl681514679

Label Image - lbl681514679

This is a prescription drug label for Cymbalta (duloxetine) by the manufacturer Lilly. The medication is in the form of a 30 mg delayed-release capsule with lot number C116094A and expiration date 07/14. The other characters may be internal codes and not relevant for general use.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.